ANKRD26 AS A MARKER FOR DIAGNOSIS OF THROMBOCYTOPENIAS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 20, 2015
app pub date -
Sep 17, 2013
filing date -
Sep 17, 2012
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
An in vitro method for diagnosing thrombocytopenia in a subject, the method includes the step of assessing the ANKRD26 platelet expression in a biological sample from the subject, wherein a ANKRD26 platelet expression is indicative of a thrombocytopenia. Also described is a kit for diagnosing a thrombocytopenia in a subject, which includes at least one ANKRD26 nucleic acid probe or oligonucleotide or antibody for assessing the ANKRD26 platelet expression in a biological sample from the subject.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully